Dr. Lorelei (Lori) Westin is a partner in the San Diego office of Wilson Sonsini Goodrich & Rosati. Lori prepares and prosecutes patent applications before the USPTO, covering therapeutic drugs, formulations, treatment methods, and diagnostics, and manages global patent portfolios to protect innovations throughout the product lifecycle. She has extensive experience in patent prosecution and litigation for companies in the animal health industry, representing clients across veterinary pharmaceuticals, medical devices, diagnostics, and animal nutrition.
Lori has litigated patent disputes in federal district courts and before the Patent Trial and Appeal Board, including post-grant review proceedings, Hatch-Waxman litigation, and infringement actions, on behalf of both patent owners and accused infringers. Her work includes conducting freedom-to-operate and invalidity analyses and advising on patent strategy for therapeutic and animal health products.
Before joining the firm, Lori served as a federal law clerk for the Honorable John A. Houston in the Southern District of California. She also was a patent agent at Howrey Simon Arnold & White. Prior to Howrey, Lori was a research scientist, serving as a senior research scientist in Advanced Technologies at Nanogen, Inc.; a research associate in the Regulatory Biology Laboratory at the Salk Institute; and a postdoctoral fellow in the Laboratory of Molecular Genetics, CMB, at the Karolinska Institute in Sweden. She is the primary author of numerous scientific and legal publications and is an inventor on seven issued U.S. patents on microchip and DNA amplification technology.
Lori has held numerous fellowships, including at the J. Aron Foundation; a Minority Postdoctoral Fellowship at the Karolinska Institute, Stockholm, Sweden, National Science Foundation; a Fulbright Fellowship; and a Pre-doctoral Fellowship at the National Science Foundation. She also earned Highest Honors as a fellow at the Centers for Academic Excellence at the Center for Law, Technology and Communications.
Dr. Lorelei (Lori) Westin is a partner in the San Diego office of Wilson Sonsini Goodrich & Rosati. Lori prepares and prosecutes patent applications before the USPTO, covering therapeutic drugs, formulations, treatment methods, and diagnostics, and manages global patent portfolios to protect innovations throughout the product lifecycle. She has extensive experience in patent prosecution and litigation for companies in the animal health industry, representing clients across veterinary pharmaceuticals, medical devices, diagnostics, and animal nutrition.
Lori has litigated patent disputes in federal district courts and before the Patent Trial and Appeal Board, including post-grant review proceedings, Hatch-Waxman litigation, and infringement actions, on behalf of both patent owners and accused infringers. Her work includes conducting freedom-to-operate and invalidity analyses and advising on patent strategy for therapeutic and animal health products.
Before joining the firm, Lori served as a federal law clerk for the Honorable John A. Houston in the Southern District of California. She also was a patent agent at Howrey Simon Arnold & White. Prior to Howrey, Lori was a research scientist, serving as a senior research scientist in Advanced Technologies at Nanogen, Inc.; a research associate in the Regulatory Biology Laboratory at the Salk Institute; and a postdoctoral fellow in the Laboratory of Molecular Genetics, CMB, at the Karolinska Institute in Sweden. She is the primary author of numerous scientific and legal publications and is an inventor on seven issued U.S. patents on microchip and DNA amplification technology.
Lori has held numerous fellowships, including at the J. Aron Foundation; a Minority Postdoctoral Fellowship at the Karolinska Institute, Stockholm, Sweden, National Science Foundation; a Fulbright Fellowship; and a Pre-doctoral Fellowship at the National Science Foundation. She also earned Highest Honors as a fellow at the Centers for Academic Excellence at the Center for Law, Technology and Communications.
- J.D., Thomas Jefferson School of Law, 2004Summa Cum Laude; Managing Editor and Editor-in-Chief, Thomas Jefferson Law Review
- Ph.D., Biology, Boston UniversityBoston University Dean's Fellow, Graduate School of Arts and Sciences
- M.A., Biology, Boston University
- B.A., Animal Physiology, University of California, San Diego, 1987UCSD Presidential Fellow and Undergraduate Research (MARC) Fellow
- Named 2025 “API Leader of Influence” by San Diego Business Journal
-
Named 2025 “Mentorship Award” Finalist by The Recorder
- Named to San Diego Business Journal’s “Top Women of Influence in Law” for 2023
- Recognized by San Diego Business Journal as 2023 “Top Woman of Influence: 50 Over 50”
- State Bar of California
- U.S. Patent and Trademark Office
- J.D., Thomas Jefferson School of Law, 2004Summa Cum Laude; Managing Editor and Editor-in-Chief, Thomas Jefferson Law Review
- Ph.D., Biology, Boston UniversityBoston University Dean's Fellow, Graduate School of Arts and Sciences
- M.A., Biology, Boston University
- B.A., Animal Physiology, University of California, San Diego, 1987UCSD Presidential Fellow and Undergraduate Research (MARC) Fellow
- Named 2025 “API Leader of Influence” by San Diego Business Journal
-
Named 2025 “Mentorship Award” Finalist by The Recorder
- Named to San Diego Business Journal’s “Top Women of Influence in Law” for 2023
- Recognized by San Diego Business Journal as 2023 “Top Woman of Influence: 50 Over 50”
- State Bar of California
- U.S. Patent and Trademark Office
Select Publications
- Co-author, "Federal Circuit Amgen Case Clarifies Important Aspects of the Biologics Price Competition and Innovation Act," Generic Pharma 2.0, July 22, 2015
- Co-author with C. Miller, D. Vollmer, R. Radtkey, D. Canter, M. Nerenberg, and J. O'Connell, "Identification of Microorganisms on a Microelectronic Chip Array," Journal of Clinical Microbiology, Vol. 39 at 1097-1104, 2001
- Co-author with X. Xu, C. Miller, L. Wang, C.F. Edman, and M. Nerenberg, "Anchored Multiplex Amplification on a Microelectronic Chip Array," Nat. Biotechnol., Vol. 18 at 199-204, 2000
- Co-author with P. Blomquist, J.F. Milligan, and Wrange, "Triple Helix DNA Alters Nucleosomal Histone DNA Interactions and Acts As a Nucleosome Barrier," Nucleic Acids Research, Vol. 23 at 2184-2191, 1995
- Co-author with L.E. Perez and I.P. Callard, "Regulation of Hepatic Vitellogenin Synthesis in the Little Skate (Raja erinacea) - Use of a Homologous Enzyme-Linked Immunosorbent Assay," Journal of Experimental Zoology, Vol. 266 at 31-39, 1993
- Co-author with L.E. Perez, "Hormonal Regulation of Hepatic Lipoproteins in Non-Mammalian Vertebrates," Thesis, Department of Biology, Boston University, March, 1992
- Co-author with L.E. Perez, D. Williams, and I.P. Callard, "Putative Apolipoprotein B-100 in the Freshwater Turtle Chrysemys picta: Effects of Estrogen and Progesterone," Comparative Biochemistry and Physiology, Vol. 103B at 707-713, 1992
- Co-author with L.E. Perez, M.F. Fenton, and I.P. Callard, "Vitellogenin-Homolog of Mammalian Apolipoproteins?" Comparative Biochemistry and Physiology, Vol. 100B at 821-826, 1991
Select Speaking Engagements
- Speaker, “Industry Speaker Series: Intellectual Property and Patent Strategies for the Emerging Growth Company,” Keck Graduate Institute, February 2022
Select Publications
- Co-author, "Federal Circuit Amgen Case Clarifies Important Aspects of the Biologics Price Competition and Innovation Act," Generic Pharma 2.0, July 22, 2015
- Co-author with C. Miller, D. Vollmer, R. Radtkey, D. Canter, M. Nerenberg, and J. O'Connell, "Identification of Microorganisms on a Microelectronic Chip Array," Journal of Clinical Microbiology, Vol. 39 at 1097-1104, 2001
- Co-author with X. Xu, C. Miller, L. Wang, C.F. Edman, and M. Nerenberg, "Anchored Multiplex Amplification on a Microelectronic Chip Array," Nat. Biotechnol., Vol. 18 at 199-204, 2000
- Co-author with P. Blomquist, J.F. Milligan, and Wrange, "Triple Helix DNA Alters Nucleosomal Histone DNA Interactions and Acts As a Nucleosome Barrier," Nucleic Acids Research, Vol. 23 at 2184-2191, 1995
- Co-author with L.E. Perez and I.P. Callard, "Regulation of Hepatic Vitellogenin Synthesis in the Little Skate (Raja erinacea) - Use of a Homologous Enzyme-Linked Immunosorbent Assay," Journal of Experimental Zoology, Vol. 266 at 31-39, 1993
- Co-author with L.E. Perez, "Hormonal Regulation of Hepatic Lipoproteins in Non-Mammalian Vertebrates," Thesis, Department of Biology, Boston University, March, 1992
- Co-author with L.E. Perez, D. Williams, and I.P. Callard, "Putative Apolipoprotein B-100 in the Freshwater Turtle Chrysemys picta: Effects of Estrogen and Progesterone," Comparative Biochemistry and Physiology, Vol. 103B at 707-713, 1992
- Co-author with L.E. Perez, M.F. Fenton, and I.P. Callard, "Vitellogenin-Homolog of Mammalian Apolipoproteins?" Comparative Biochemistry and Physiology, Vol. 100B at 821-826, 1991
Select Speaking Engagements
- Speaker, “Industry Speaker Series: Intellectual Property and Patent Strategies for the Emerging Growth Company,” Keck Graduate Institute, February 2022
Biological Sciences and Biotechnology
- Antibody
- Antigen presentation
- Biochemical assays
- Biologics
- Cancer therapeutics
- CAR-T cells
- Genetics
- Genomics
- Immunobiology
- Molecular biology
Diagnostics and Medical Devices
- Biomedical devices
- Biosensors
- Diagnostics
- Medical devices
- Point-of-care testing (POCT)
- Wearable analyte sensors
Genomics and Data Analysis
- Functional genomics
- Next-generation sequencing
- Sequencing
- Single-cell sequencing
Miscellaneous
- Animal health
- Cancer
- Food science
- Formulations
- Infectious diseases
- Litigation/PTAB/Oppositions
- Physiology
Biological Sciences and Biotechnology
- Antibody
- Antigen presentation
- Biochemical assays
- Biologics
- Cancer therapeutics
- CAR-T cells
- Genetics
- Genomics
- Immunobiology
- Molecular biology
Diagnostics and Medical Devices
- Biomedical devices
- Biosensors
- Diagnostics
- Medical devices
- Point-of-care testing (POCT)
- Wearable analyte sensors
Genomics and Data Analysis
- Functional genomics
- Next-generation sequencing
- Sequencing
- Single-cell sequencing
Miscellaneous
- Animal health
- Cancer
- Food science
- Formulations
- Infectious diseases
- Litigation/PTAB/Oppositions
- Physiology
Wilson Sonsini’s All Eyes on AI: Regulatory, Litigation, and Transactional Developments closely follows the evolving regulatory landscape for artificial intelligence (AI) in the U.S., new EU regulations for AI, international developments, litigation, recent deals highlights, firm publications, and other AI and machine learning highlights. This latest Q3/Q4 2025 edition features:
The latest edition of All Eyes on AI addresses the White House’s AI Action Plan, the USPTO’s plan to accelerate patent review, the EC’s details of the EU AI Act for GPAI requirements, and the Japanese market’s study on generative AI markets.
- Privacy Policy
- Terms of Use
- Accessibility